Financial Performance - The total operating revenue for 2023 was CNY 37,738.35 million, representing a 16.27% increase compared to the previous year[4] - The operating profit for 2023 was CNY -5,240.42 million, a decline of 362.05% from the previous year's profit[4] - The net profit attributable to shareholders for 2023 was CNY -5,332.26 million, a decrease of 404.17% year-over-year[5] - The basic earnings per share for 2023 was CNY -0.74, down 393.33% from the previous year[5] Assets and Equity - Total assets at the end of the reporting period were CNY 74,835.08 million, a decrease of 11.10% from the beginning of the year[5] - The equity attributable to shareholders decreased to CNY 58,278.65 million, down 10.73% from the previous period[5] Research and Development - The company reported an increase in R&D expenses due to the progress of fundraising projects, contributing to the overall loss[6] Impairment and Financial Accuracy - Impairment provisions were made for goodwill and long-term equity investments, impacting the net profit significantly[6][8] - The company acknowledged the need for improved accuracy and timeliness in financial data calculations and disclosures[9] Investor Relations - The board expressed sincere apologies for the impact of the performance forecast revision on investors[9]
零点有数(301169) - 2023 Q4 - 年度业绩预告(更正)